Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies
Rodolphe Thiébaut(Institut national de recherche en sciences et technologies du numérique), Michael M. Lederman, Gianpiero D’Offizi(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Roberto F. Speck(University of Zurich), Prudence Ive(Perinatal HIV Research Unit), Giuseppe Tambussi(San Raffaele University of Rome), Margaret A. Fischl, Irini Sereti(National Institutes of Health), Jean-François Delfraissy(Inserm), Sharne Foulkes, Salvatore Casari(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Ven Natarajan(Leidos (United States)), Ana Jarné(Institut national de recherche en sciences et technologies du numérique), Yves Lévy(Inserm), Thérèse Croughs(Neovacs (France)), Jean-Pierre Routy(McGill University Health Centre), Daniel Commenges(Institut national de recherche en sciences et technologies du numérique)
Cited by 80
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
|New England Journal of Medicine|1987|3k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k
The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
|New England Journal of Medicine|1987|1.2k